Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Wyeth submits NDA for desvenlafaxine extended release

Dec. 27, 2005

Approval letter for Biovail's ODT formulation of citalopram hydrobromide

Dec. 27, 2005

Genzyme acquires gene therapy assets from Avigen

Dec. 27, 2005

Allopregnanolone shows efficacy in a rat model of spontaneous recurrent seizures

Dec. 27, 2005

NeuroSearch updates progress of NS-1209

Dec. 23, 2005

New data on BIA-2-093 presented at American epilepsy meeting

Dec. 23, 2005

Nutra Pharma reports findings in MS

Dec. 23, 2005

MEM-1003 is cognitively safe in patients with Alzheimer's disease

Dec. 22, 2005

New galanin-3 receptor antagonists for depression and anxiety

Dec. 22, 2005

Memory signs agreement for development of MEM-1003 for bipolar disorder

Dec. 22, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...